HOME › DRUGS › CYCLOPHOSPHAMIDE
ACTIVE SUBSTANCE / INN

CYCLOPHOSPHAMIDE

Brand name(s): NEOSAR, CYTOXAN (LYOPHILIZED), LYOPHILIZED CYTOXAN, FRINDOVYX, CYCLOPHOSPHAMIDE, CYTOXAN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA210852
ANDA088371
ACTIVE SUBSTANCE
Cyclophosphamide
REGULATORS
FDA
SPONSORS / MAH
TEVA PARENTERAL, HETERO LABS LIMITED, BAXTER HLTHCARE
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CYCLOPHOSPHAMIDENDA203856HIKMAPrescription
CYCLOPHOSPHAMIDEANDA088371BAXTER HLTHCAREDiscontinued
NEOSARANDA040015TEVA PARENTERALDiscontinued
CYTOXANNDA012141BAXTER HLTHCAREPrescription
FRINDOVYXNDA210852AVYXA HOLDINGSPrescription
CYCLOPHOSPHAMIDEANDA219271HETERO LABS LIMITEDNone (Tentative Approval)
CYTOXAN (LYOPHILIZED)NDA012142BAXTER HLTHCAREDiscontinued
LYOPHILIZED CYTOXANNDA012142BAXTER HLTHCAREDiscontinued
CYTOXANNDA012142BAXTER HLTHCAREDiscontinued

FULL INTELLIGENCE ON CYCLOPHOSPHAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →